DDX42 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.203000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.650550E-01
Normal-vs-Stage2
2.230200E-01
Normal-vs-Stage3
2.984000E-01
Normal-vs-Stage4
1.801240E-01
Stage1-vs-Stage2
4.222800E-01
Stage1-vs-Stage3
9.619600E-01
Stage1-vs-Stage4
6.886200E-01
Stage2-vs-Stage3
4.697000E-01
Stage2-vs-Stage4
8.135800E-01
Stage3-vs-Stage4
7.393600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.562210E-01
Normal-vs-AfricanAmerican
9.781200E-01
Normal-vs-Asian
6.129000E-01
Caucasian-vs-AfricanAmerican
4.439600E-01
Caucasian-vs-Asian
2.277200E-01
AfricanAmerican-vs-Asian
6.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.349410E-01
Normal-vs-Female
3.372400E-01
Male-vs-Female
4.338200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.269200E-01
Normal-vs-Age(41-60Yrs)
3.693000E-01
Normal-vs-Age(61-80Yrs)
1.825180E-01
Normal-vs-Age(81-100Yrs)
1.158200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.977600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.084400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.310000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.082280E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.314240E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.928600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.547600E-01
Normal-vs-Daily Drinker
9.638300E-02
Normal-vs-Weekly Drinker
1.089980E-01
Normal-vs-Occasional Drinker
3.249600E-01
Normal-vs-Social Drinker
4.575800E-01
Non Drinker-vs-Daily Drinker
5.476000E-01
Non Drinker-vs-Weekly Drinker
6.852200E-01
Non Drinker-vs-Occasional Drinker
3.590200E-01
Non Drinker-vs-Social Drinker
2.217800E-01
Daily Drinker-vs-Weekly Drinker
8.983800E-01
Daily Drinker-vs-Occasional Drinker
9.744500E-02
Daily Drinker-vs-Social Drinker
4.898500E-02
Weekly Drinker-vs-Occasional Drinker
1.547840E-01
Weekly Drinker-vs-Social Drinker
8.084200E-02
Occasional Drinker-vs-Social Drinker
6.562400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.292000E-02
Normal-vs-Grade 2
2.174100E-02
Normal-vs-Grade 3
6.556400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.425000E-01
Grade 1-vs-Grade 3
5.712600E-01
Grade 1-vs-Grade 4
4.292000E-02
Grade 2-vs-Grade 3
3.192000E-01
Grade 2-vs-Grade 4
2.174100E-02
Grade 3-vs-Grade 4
6.556400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.719900E-02
Normal-vs-NonDiabetic
3.576600E-01
Diabetic-vs-NonDiabetic
7.227900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.911400E-01
Normal-vs-NoPancreatitis
2.287200E-01
Pancreatitis-vs-NoPancreatitis
5.542000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.449400E-01
Normal-vs-N1
1.359640E-01
N0-vs-N1
1.597190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.697400E-01
Normal-vs-TP53-NonMutant
4.021600E-01
TP53-Mutant-vs-TP53-NonMutant
6.305600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
